European multinational corporations are expanding their manufacturing footprints in the United States, directing billions of dollars in foreign direct investment (FDI) to secure supply chains and meet regional demand. On June 22, 2026, Danish pharmaceutical manufacturer Novo Nordisk announced a $4.1 billion investment to construct a second fill-finish manufacturing facility in Clayton, North Carolina, according to the Wall Street Journal. Reuters and Bloomberg report that the expansion is designed to double the company’s US production footprint for its metabolic and chronic disease treatments. This capital deployment specifically addresses the high market demand for its treatments, Wegovy and Ozempic, by localizing critical manufacturing steps.
In tandem with the pharmaceutical sector, the consumer goods industry is also seeing substantial European capital inflows. The Lego Group is advancing construction on its new manufacturing facility in Chesterfield County, Virginia, representing an investment of more than $1 billion, according to the Associated Press. Reuters and the Wall Street Journal report that the carbon-neutral plant is designed to shorten supply chains to the North American market, reducing transport distances and enhancing regional distribution efficiency. The project is also expected to create over 1,760 jobs once operational.
These investments highlight a growing trend of nearshoring among European companies seeking to insulate themselves from global supply chain disruptions. By establishing large-scale manufacturing hubs directly within the United States, both Novo Nordisk and the Lego Group are reducing their reliance on transatlantic shipping and improving their operational agility. This strategic positioning allows companies to respond more rapidly to market fluctuations while contributing to the regional economy through job creation and sustainable industrial development.
The trade implications of these moves are significant. As global logistics remain vulnerable to geopolitical and economic volatility, localizing production has transitioned from a cost-saving measure to a core risk-mitigation strategy. Novo Nordisk’s expansion in North Carolina ensures that critical healthcare products are manufactured closer to their primary consumer base, reducing potential trade bottlenecks. Similarly, Lego’s carbon-neutral facility in Virginia aligns with corporate sustainability goals while optimizing regional logistics. These projects demonstrate that the United States remains an attractive destination for high-value greenfield FDI, offering robust infrastructure and a skilled workforce for global manufacturers.
#USManufacturing #ForeignDirectInvestment #SupplyChainResilience #Pharmaceuticals #Lego